Mulmit

Larimar Therapeutics, Inc.Larimar Therapeutics, Inc.

LRMR Nasdaq

Annual financials

PeriodRevenueOperating incomeNet incomeEPS
2019-12-310-23,214,000-23,132,000
2018-12-310-61,122,000-61,368,000
2017-12-310-52,999,000-52,028,000
2016-12-310-58,225,000-57,878,000
2015-12-310-73,813,000-74,286,000

Insider filings (Forms 3/4/5)

DateOwnerTitleShares
2026-07-06Hamilton Thomas Edward50,000
2026-05-19Flynn James E* Director by Deputization55,150
2026-05-19LEFF JONATHAN S55,150
2026-05-19SHERMAN JEFFREY W55,150
2026-05-19Truitt Joseph55,150
2026-05-19THOMAS FRANK E55,150
2026-05-19Hamilton Thomas Edward55,150
2026-02-27Flynn James E* Director by Deputization1,084,010
2026-02-27Flynn James E* Director by Deputization1,084,012
2026-02-27Flynn James E* Director by Deputization831,978
2026-02-27Flynn James E* Director by Deputization2,000,000
2026-02-27Hamilton Thomas Edward100,000

8-K events

FiledItems
2026-08-04Results of operations · Other events · Financial statements and exhibits
2026-06-29Other events · Financial statements and exhibits
2026-05-19Submission of matters to a vote
2026-05-14Results of operations · Other events · Financial statements and exhibits
2026-03-19Results of operations · Financial statements and exhibits
2026-03-09Other events · Financial statements and exhibits
2026-02-27Entry into a material agreement · Financial statements and exhibits
2026-02-24Other events · Financial statements and exhibits
데이터를 불러오는 중입니다…Loading…

가격 차트Price chart

차트를 불러오는 중입니다…Loading chart…